Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Lipid-Derived Biomarkers for NAION
Retina Research & Innovations News

Lipid-Derived Biomarkers for NAION

TVST study reveals potential new metabolic signal in nonarteritic anterior ischemic optic neuropathy

3/13/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Objective:

To explore the potential of lipid-derived indices as systemic biomarkers associated with nonarteritic anterior ischemic optic neuropathy (NAION).

Key Findings:
  • Traditional lipid parameters were largely normal in both groups, but triglycerides were higher and HDL-C lower in the NAION group.
  • Both the atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index were significantly elevated in NAION patients compared to controls.
  • TyG remained significantly higher even after adjusting for fasting blood sugar.
  • Neither AIP nor TyG correlated with functional or structural severity measures of NAION.
Interpretation:

The findings suggest that systemic metabolic vulnerability may be measurable in NAION patients, indicating a background metabolic milieu that predisposes to ischemic events rather than reflecting acute injury severity.

Limitations:
  • The study is retrospective, single-center, and relatively small.
  • Exclusion of patients with known hyperlipidemia may limit generalizability.
Conclusion:

NAION may be as much a systemic metabolic disease as a local optic nerve event, warranting further prospective studies to assess the predictive value of these indices.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: